Kardium private stock trade

Kardium

Legal NameKardium Inc.
HeadquartersBurnaby
SectorHealthTech

Kardium is a medical technology company focused on developing advanced solutions for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. Their flagship product, the Globe® Mapping and Ablation System, integrates innovative mapping and ablation technologies to provide physicians with real-time, three-dimensional visualization and precise control during cardiac ablation procedures. By combining mapping, navigation, and therapy delivery into a single platform, Kardium's system aims to improve procedural efficiency, enhance patient outcomes, and reduce the complexity associated with treating AF.

Learn more about Kardium IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Kardium, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Kardium, log in to ZXData or contact us to request access.

Similar Companies

View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.